全文获取类型
收费全文 | 17542篇 |
免费 | 1607篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 577篇 |
妇产科学 | 430篇 |
基础医学 | 2574篇 |
口腔科学 | 450篇 |
临床医学 | 2016篇 |
内科学 | 3112篇 |
皮肤病学 | 349篇 |
神经病学 | 1495篇 |
特种医学 | 573篇 |
外科学 | 2088篇 |
综合类 | 293篇 |
一般理论 | 14篇 |
预防医学 | 1835篇 |
眼科学 | 351篇 |
药学 | 1113篇 |
中国医学 | 47篇 |
肿瘤学 | 1674篇 |
出版年
2022年 | 130篇 |
2021年 | 337篇 |
2020年 | 246篇 |
2019年 | 315篇 |
2018年 | 334篇 |
2017年 | 266篇 |
2016年 | 324篇 |
2015年 | 342篇 |
2014年 | 488篇 |
2013年 | 748篇 |
2012年 | 1034篇 |
2011年 | 1034篇 |
2010年 | 606篇 |
2009年 | 577篇 |
2008年 | 909篇 |
2007年 | 974篇 |
2006年 | 901篇 |
2005年 | 853篇 |
2004年 | 878篇 |
2003年 | 832篇 |
2002年 | 753篇 |
2001年 | 355篇 |
2000年 | 357篇 |
1999年 | 347篇 |
1998年 | 210篇 |
1997年 | 194篇 |
1996年 | 145篇 |
1995年 | 154篇 |
1994年 | 138篇 |
1993年 | 150篇 |
1992年 | 309篇 |
1991年 | 278篇 |
1990年 | 242篇 |
1989年 | 248篇 |
1988年 | 182篇 |
1987年 | 211篇 |
1986年 | 199篇 |
1985年 | 233篇 |
1984年 | 158篇 |
1983年 | 147篇 |
1982年 | 122篇 |
1981年 | 108篇 |
1979年 | 142篇 |
1978年 | 104篇 |
1977年 | 100篇 |
1976年 | 103篇 |
1974年 | 97篇 |
1973年 | 111篇 |
1972年 | 111篇 |
1971年 | 103篇 |
排序方式: 共有10000条查询结果,搜索用时 453 毫秒
11.
12.
13.
Judith Bernardini Valerie Price Ana Figueiredo Aase Riemann Dora Leung 《Peritoneal dialysis international》2006,26(6):658-663
OBJECTIVE: To survey nurses around the world about current practices for peritoneal dialysis (PD) home training programs. DESIGN: Random sampling of nurses to complete a written survey from the International Society for Peritoneal Dialysis Nursing Liaison Committee. Settings: United States, Canada, South America (Brazil, Columbia), The Netherlands, Hong Kong. METHODS: Surveys and responses were sent by fax whenever possible, or by regular mail, or hand carried, or conducted by telephone. Results were stratified by geographic areas as well as by cumulative responses and were expressed as medians with ranges. Kruskal-Wallis was used to evaluate differences in responses. Associations between variables were tested with Pearson correlation. Univariate regression analysis was used to evaluate the impact of variables on peritonitis rates. Variables with p < 0.10 were included in a multivariate analysis. RESULTS: A total of 317 nurses responded: 88 in the United States, 46 in Canada, 58 in South America, 58 in Hong Kong, and 67 in The Netherlands. This represented 37% of all surveys distributed. Respondents had a median of 12 years' experience in nephrology (range 1-35 years), but only 31% had a formal background in adult education. Nearly half received their guidance to patient training from a nurse colleague, 11% were guided by a corporate colleague, and 8% were simply self-taught. Clinics responding had a median of 30 PD patients (range 1-400) and reported they trained a median of 8 patients per year (range 0-86). Reported peritonitis rates were a median 0.46 per year or 1 episode every 26 months. Peritonitis rates, however, were not known by 53% of respondents. Total training time per patient had a very wide range of hours, from 6 to 96. There was no correlation between training time and peritonitis rates among the study respondents (p = 0.38), nor with any other variables. CONCLUSIONS: There is wide variation in practices for PD patient training programs within countries and around the world. Training time did not appear to be related to peritonitis rates. Randomized trials of training practices are needed to determine which approaches produce the best outcomes for patients. 相似文献
14.
15.
Mark S. Wallace Steven G. Charapata Robert Fisher Michael Byas‐Smith Peter S. Staats Martha Mayo Dawn McGuire David Ellis 《Neuromodulation》2006,9(2):75-86
Objective. The safety and efficacy of intrathecal (IT) ziconotide was studied in a randomized, double‐blind, placebo‐controlled trial. Materials and Methods. Patients (169 ziconotide, 86 placebo) with severe chronic nonmalignant pain unresponsive to conventional therapy and a visual analog scale of pain intensity (VASPI score) ≥ 50 mm were treated over a 6‐day period in an inpatient hospital setting. Initial starting dose was 0.4 µg/hour and was titrated to analgesia or intolerance (maximum dose 7.0 µg/hour). The starting and maximum doses were reduced to 0.1 µg/hour and 2.4 µg/hour, respectively, due to adverse events (AEs). Results. The mean percent reduction in VASPI score from baseline was 31.2% and 6.0% for ziconotide‐ and placebo‐treated patients, respectively (p ≤ 0.001). During the initial titration phase, a significantly greater percentage of patients in the ziconotide group compared to the placebo group reported AEs, including abnormal gait, amblyopia, dizziness, nausea, nystagmus, pain, urinary retention, and vomiting. Conclusion. Ziconotide provided significant analgesia in patients for whom conventional therapy failed. However, there was a considerable incidence of ziconotide‐associated AEs due to the rapid titration and high doses administered. 相似文献
16.
17.
18.
19.
Ann G Schwartz Geoffrey M Prysak Valerie Murphy Fulvio Lonardo Harvey Pass Jan Schwartz Sam Brooks 《Clinical cancer research》2005,11(20):7280-7287
PURPOSE: A role for estrogens in determining lung cancer risk and prognosis is suggested by reported sex differences in susceptibility and survival. Archival lung tissue was evaluated for the presence of nuclear estrogen receptor (ER)-alpha and ER-beta and the relationship between ER status, subject characteristics, and survival. EXPERIMENTAL DESIGN: Paraffin-embedded lung tumor samples were obtained from 214 women and 64 men from two population-based, case-control studies as were 10 normal lung autopsy samples from patients without cancer. Nuclear ER-alpha and ER-beta expression was determined by immunohistochemistry. Logistic regression was used to identify factors associated with ER positivity and Cox proportional hazards models were used to measure survival differences by ER status. RESULTS: Neither tumor (0 of 94) nor normal (0 of 10) lung tissue stained positive for ER-alpha. Nuclear ER-beta positivity was present in 61% of tumor tissue samples (170 of 278; 70.3% in men and 58.3% in women) and 20% of normal tissue samples (2 of 10; P = 0.01). In multivariate analyses, females were 46% less likely to have ER-beta-positive tumors than males (odds ratio, 0.54; 95% confidence interval, 0.27-1.08). This relationship was stronger and statistically significant in adenocarcinomas (odds ratio, 0.40; 95% confidence interval, 0.18-0.89). Women with ER-beta-positive tumors had a nonsignificant 73% (P = 0.1) increase in mortality, whereas men with ER-beta-positive tumors had a significant 55% (P = 0.04) reduction in mortality compared with those with ER-beta-negative tumors. CONCLUSIONS: This study suggests differential expression by sex and influence on survival in men of nuclear ER-beta in lung cancer, particularly in adenocarcinomas. 相似文献
20.